Actively Recruiting
A Comprehensive Breast Cancer Survivorship Biorepository Collecting Blood Samples, Surveys, and Medical Records
Led by University of Southern California · Updated on 2026-05-28
1300
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
Sponsors
U
University of Southern California
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are collecting blood samples, clinical information, and self-reported data from women who have survived stage I to III invasive breast cancer. The goal is to create a detailed biorepository that will support future studies exploring the links between individual, molecular, and genetic factors and cancer outcomes. This observational study is sponsored by the University of Southern California and aims to enhance breast cancer survivorship research. Participants will provide blood samples and complete surveys about their lifestyle, health, and social factors. Researchers will also review the participants' medical records to gather comprehensive information on treatment history, disease status, and survivorship issues. This biorepository will be maintained and accessible for future breast cancer and survivorship studies. During the study, participants will complete quality-of-life questionnaires and surveys, provide blood samples, and allow researchers to review their medical records. The primary outcome is the establishment of the biorepository over a 5-year period. The study involves ongoing data collection and monitoring, with no intervention or treatment administration, and participation involves regular communication and assessments to support future research efforts.
CONDITIONS
Brief Title
Breast Cancer Survivorship Biorepository
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women of all racial and ethnic groups 18 years of age or older
- Diagnosis of invasive breast cancer (stages I-III) within the past 7 years
- Completed active treatment for breast cancer including surgery, chemotherapy, HER2-directed therapy, and radiation
- Prior participation in clinical trials is allowed
You will not qualify if you...
- Currently receiving treatment as part of an interventional clinical trial
- Stage IV (metastatic) breast cancer
- History of cancer recurrence except following ductal carcinoma in situ
- Unable to provide informed consent
- Unable to speak English, Spanish, Chinese, or Korean
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Duration - Up to 5 years
Participants complete surveys, undergo collection of blood samples, and have their medical records reviewed to contribute to the breast cancer survivorship biorepository.
1 to 2 visits depending on data collection schedule
Trial Site Locations
Total: 1 location
1
USC / Norris Comprehensive Cancer Center
Los Angeles, California, United States, 90033
Actively Recruiting
Research Team
A
Audrey Saghian, MPH
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here